Inter-country variations in anti-asthmatic drug prescriptions for children. Systematic review of studies published during the 2000-2009 period.
Marina Bianchi, Antonio Clavenna, Maurizio Bonati
Index: Eur. J. Clin. Pharmacol. 66(9) , 929-36, (2010)
Full Text: HTML
Abstract
The objective of this study was to analyse inter-and intra-country quantitative and qualitative differences in anti-asthmatic prescriptions to children and adolescents.A literature search was performed in EMBASE and MEDLINE to identify pharmaco-epidemiological studies published from January 1, 2000 to December 31, 2008 in which anti-asthmatic prescription prevalence in out-hospital children was measured. A meta-analytic weighted average and 95% confidence intervals of prescription prevalences were calculated using a random-effect(s) model. Inter- and intra-country quantitative and, where possible, qualitative prescribing patterns were compared and assessed.Twelve studies were identified (ten from Europe, one from Canada and one from the USA), but epidemiological indicators varied widely, and only eight were suitable for meta-analysis. The data from these studies revealed inter-country quantitative differences in prescription prevalences in the overall population
Related Compounds
Related Articles:
2014-08-30
[Rapid Commun. Mass Spectrom. 28(16) , 1829-39, (2015)]
Intranasal flunisolide treatment in patients with non-allergic rhinitis.
2011-01-01
[Int. J. Immunopathol. Pharmacol. 24(2) , 401-9, (2011)]
Evaluation of efficacy and safety of flunisolide hydrofluoroalkane for the treatment of asthma.
2003-03-01
[Clin. Ther. 25(3) , 776-98, (2003)]
2009-01-01
[Int. J. Immunopathol. Pharmacol. 22(2) , 363-70, (2009)]
Late (≥ 7 days) inhalation corticosteroids to reduce bronchopulmonary dysplasia in preterm infants.
2012-01-01
[Cochrane Database Syst. Rev. 4 , CD002311, (2012)]